Preventive Brain Health Testing
Made Meaningful

We are a grant-funded, mission-driven organization that aims to expand access to brain biomarkers through an at-home "cholesterol test for the brain" paired with actionable education.

$409 Billion

Projected 2026 health and long-term care costs for Alzheimer’s and other dementias¹

64% of costs

Expected to be covered by Medicare and Medicaid in 2026 ($263 Billion)²

45% of Dementia Cases

Potentially preventable by addressing 14 modifiable risk factors³

47 Million Americans

Have early, silent markers of Alzheimer’s developing in their brains⁴

Democratizing Access to Brain Biomarker Testing

Today, advanced brain biomarker testing can be difficult to access and costly—particularly for people without convenient access to specialized neurological care.

AlzLabs is working to change that. As a grant-funded, mission-driven organization, we are developing innovative approaches to make brain biomarker testing more accessible, convenient, and affordable, including at-home testing and lower-cost testing models.

Access to care and cost should not prevent people from meaningful information about brain health. Our goal is to make emerging brain health technologies widely available in 2027; through novel sample storage techniques and measuring >100 brain proteins from ≤10 drops of blood from home, we aim to transform risk assessment decades before symptoms begin and provide a roadmap for precision medicine-based care.

AlzLabs in the News

More →
Contact

Get in touch

If you are a person interested in maintaining brain health, a physician, or a researcher, we'd love to hear from you. Help bring our mission to life.

Thanks for your submission! To help design your ideal brain health experience, please complete this survey.
Oops! Something went wrong while submitting the form.
By submitting this form, you agree to receive communications from AlzLabs. You can unsubscribe at any time.